Best Biotechnology Industry Stocks to Invest in Today
Discover leading companies in the biotechnology industry with transparent fundamentals and ESG context. Explore 10 carefully selected stocks updated periodically.
Data updates periodically • 10 stocks analyzed • ESG context included
Biotechnology Industry Analysis
Biotechnology companies advancing innovative therapies, diagnostic solutions, and medical technologies.
Industry Statistics
Growth Drivers
Precision medicine advancement, gene therapy breakthroughs, aging population needs, rare disease focus, technology convergence, and collaborative research models.
Industry Overview
Biotechnology industry focuses on using biological processes to develop therapeutic drugs, diagnostic tools, and medical devices, with emphasis on rare diseases, personalized medicine, and breakthrough treatments.
Key Characteristics
Research-intensive operations, clinical trial dependencies, regulatory approval requirements, intellectual property focus, high-risk high-reward profiles, and scientific talent requirements.
ESG Considerations
Patient access to innovative therapies, orphan disease treatment, ethical clinical trials, global health initiatives, sustainable manufacturing, and transparent research practices.
Regulatory Environment
FDA biologics regulations, orphan drug incentives, clinical trial protocols, manufacturing quality standards, and international harmonization requirements.
Top Biotechnology Industry Stock Picks Today
Interactive table showing the best-performing stocks with ESG ratings and key financial metrics
Showing 1 to 10 of 10 stocks
| ESG Rating | Action | ||||
|---|---|---|---|---|---|
AbbVie Inc. ABBV | — | $1.1B | 60.0/100 | View details | |
Amgen Inc. AMGN | — | $1.1B | 81.0/100 | View details | |
| — | $1.7B | — | View details | ||
Biogen B11 | — | $6.2B | 71.0/100 | View details | |
| — | $11.2B | 26.0/100 | View details | ||
| — | $17.7B | — | View details | ||
| — | $6.8B | — | View details | ||
| — | $20.2B | 51.0/100 | View details | ||
| — | $593.4M | — | View details | ||
Zymeworks Inc. ZYME | — | $16.7B | — | View details |